1. Home
  2. JAGX vs NBY Comparison

JAGX vs NBY Comparison

Compare JAGX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • NBY
  • Stock Information
  • Founded
  • JAGX 2013
  • NBY 2000
  • Country
  • JAGX United States
  • NBY United States
  • Employees
  • JAGX N/A
  • NBY N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • JAGX Health Care
  • NBY
  • Exchange
  • JAGX Nasdaq
  • NBY Nasdaq
  • Market Cap
  • JAGX 3.8M
  • NBY 3.4M
  • IPO Year
  • JAGX N/A
  • NBY 2007
  • Fundamental
  • Price
  • JAGX $8.06
  • NBY $0.57
  • Analyst Decision
  • JAGX
  • NBY Strong Buy
  • Analyst Count
  • JAGX 0
  • NBY 1
  • Target Price
  • JAGX N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • JAGX 66.3K
  • NBY 69.0K
  • Earning Date
  • JAGX 05-13-2025
  • NBY 05-08-2025
  • Dividend Yield
  • JAGX N/A
  • NBY N/A
  • EPS Growth
  • JAGX N/A
  • NBY N/A
  • EPS
  • JAGX N/A
  • NBY N/A
  • Revenue
  • JAGX $11,689,000.00
  • NBY $9,781,000.00
  • Revenue This Year
  • JAGX $38.22
  • NBY $23.91
  • Revenue Next Year
  • JAGX $39.96
  • NBY $32.05
  • P/E Ratio
  • JAGX N/A
  • NBY N/A
  • Revenue Growth
  • JAGX 19.75
  • NBY N/A
  • 52 Week Low
  • JAGX $4.02
  • NBY $0.36
  • 52 Week High
  • JAGX $540.00
  • NBY $9.10
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 57.58
  • NBY 48.42
  • Support Level
  • JAGX $5.00
  • NBY $0.56
  • Resistance Level
  • JAGX $6.13
  • NBY $0.62
  • Average True Range (ATR)
  • JAGX 0.87
  • NBY 0.05
  • MACD
  • JAGX 0.72
  • NBY 0.01
  • Stochastic Oscillator
  • JAGX 88.07
  • NBY 68.88

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: